CV Sciences Inc (CVSI)

[Wolf-man jack]

The 2019-07-17
Application status is Pending

Patent has not been rejected. Thank you agent 007 from the Y. Brevin . Agent James Brevin ‘Proof is in the Pudding ‘ you understand

“Proof that CVSI's patent for CVSI-007 to treat smokeless tobacco addiction is not in "final rejection" status. Lawsuit has no merit. Application status is still "pending".”



Abstract:
In one aspect, a method of treating smokeless tobacco addiction comprising administering to an individual in need thereof a pharmaceutical composition comprising nicotine, a therapeutically effective amount of cannabidiol, and a pharmaceutically acceptable vehicle therefor. In some aspects, the composition is administered transmucosally, such as in an oral dosage form or nasal spray. In other aspects, the composition is administered transdermally. In another aspect, a chewable gum contains nicotine in at least a base portion and cannabidiol in at least an outer portion thereof.

https://patents.google.com/patent/US20170326126A1/en

http://www.freepatentsonline.com/y2017/0326126.html

Inventors:
Williams, Jonnie R. (Sarasota, FL, US)
Application Number:
15/426617
Publication Date:
11/16/2017
Filing Date:
02/07/2017
Export Citation:
Click for automatic bibliography generation
Assignee:
CV Sciences, Inc. (San Diego, CA, US)
International Classes:
A61K31/4439; A61K9/00; A61K9/68; A61K31/05
View Patent Images:
Download PDF 20170326126 PDF help